Takara Bio Inc. (4974.T)
JPY 1002.0
(-0.2%)
JPY 1002.0
(-0.2%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 43.5 Billion JPY | -44.33% |
| 2022 | 78.14 Billion JPY | 15.43% |
| 2021 | 67.69 Billion JPY | 46.9% |
| 2020 | 46.08 Billion JPY | 33.33% |
| 2019 | 34.56 Billion JPY | -3.56% |
| 2018 | 35.84 Billion JPY | 10.92% |
| 2017 | 32.31 Billion JPY | 10.0% |
| 2016 | 29.37 Billion JPY | -1.19% |
| 2015 | 29.72 Billion JPY | 14.48% |
| 2014 | 25.96 Billion JPY | 8.63% |
| 2013 | 23.9 Billion JPY | 16.25% |
| 2012 | 20.56 Billion JPY | 5.04% |
| 2011 | 19.57 Billion JPY | 4.49% |
| 2010 | 18.73 Billion JPY | -3.04% |
| 2009 | 19.32 Billion JPY | 2.18% |
| 2008 | 18.91 Billion JPY | -6.73% |
| 2007 | 20.27 Billion JPY | -3.36% |
| 2006 | 20.98 Billion JPY | 26.9% |
| 2005 | 16.53 Billion JPY | 20.82% |
| 2004 | 13.68 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 8.49 Billion JPY | -38.33% |
| 2023 Q4 | 13.77 Billion JPY | 29.69% |
| 2023 Q3 | 10.61 Billion JPY | 6.82% |
| 2023 Q2 | 9.94 Billion JPY | 8.33% |
| 2023 Q1 | 9.17 Billion JPY | -48.84% |
| 2023 FY | 43.5 Billion JPY | -44.33% |
| 2022 Q3 | 27.61 Billion JPY | 49.41% |
| 2022 FY | 78.14 Billion JPY | 15.43% |
| 2022 Q1 | 14.1 Billion JPY | -36.02% |
| 2022 Q2 | 18.48 Billion JPY | 31.08% |
| 2022 Q4 | 17.93 Billion JPY | -35.06% |
| 2021 Q2 | 16.27 Billion JPY | 6.59% |
| 2021 Q3 | 14.1 Billion JPY | -13.34% |
| 2021 FY | 67.69 Billion JPY | 46.9% |
| 2021 Q4 | 22.04 Billion JPY | 56.22% |
| 2021 Q1 | 15.27 Billion JPY | -7.65% |
| 2020 Q4 | 16.53 Billion JPY | 36.04% |
| 2020 Q2 | 10.45 Billion JPY | 50.69% |
| 2020 FY | 46.08 Billion JPY | 33.33% |
| 2020 Q1 | 6.93 Billion JPY | -30.67% |
| 2020 Q3 | 12.15 Billion JPY | 16.27% |
| 2019 FY | 34.56 Billion JPY | -3.56% |
| 2019 Q2 | 7.8 Billion JPY | -9.83% |
| 2019 Q1 | 8.65 Billion JPY | -13.09% |
| 2019 Q3 | 8.1 Billion JPY | 3.95% |
| 2019 Q4 | 10 Billion JPY | 23.42% |
| 2018 Q2 | 8.52 Billion JPY | -3.66% |
| 2018 Q4 | 9.95 Billion JPY | 16.85% |
| 2018 Q3 | 8.51 Billion JPY | -0.06% |
| 2018 Q1 | 8.84 Billion JPY | -8.47% |
| 2018 FY | 35.84 Billion JPY | 10.92% |
| 2017 Q3 | 8.52 Billion JPY | 9.64% |
| 2017 Q2 | 7.77 Billion JPY | 22.28% |
| 2017 Q1 | 6.35 Billion JPY | -27.21% |
| 2017 Q4 | 9.66 Billion JPY | 13.45% |
| 2017 FY | 32.31 Billion JPY | 10.0% |
| 2016 Q2 | 6.89 Billion JPY | 9.31% |
| 2016 Q3 | 7.44 Billion JPY | 8.02% |
| 2016 FY | 29.37 Billion JPY | -1.19% |
| 2016 Q4 | 8.73 Billion JPY | 17.24% |
| 2016 Q1 | 6.3 Billion JPY | -30.11% |
| 2015 Q2 | 7.49 Billion JPY | 30.12% |
| 2015 FY | 29.72 Billion JPY | 14.48% |
| 2015 Q4 | 9.02 Billion JPY | 21.13% |
| 2015 Q3 | 7.44 Billion JPY | -0.63% |
| 2015 Q1 | 5.76 Billion JPY | -33.6% |
| 2014 Q3 | 6.32 Billion JPY | 2.1% |
| 2014 Q4 | 8.67 Billion JPY | 37.24% |
| 2014 FY | 25.96 Billion JPY | 8.63% |
| 2014 Q1 | 4.77 Billion JPY | -38.24% |
| 2014 Q2 | 6.19 Billion JPY | 29.57% |
| 2013 Q3 | 5.89 Billion JPY | -3.55% |
| 2013 Q4 | 7.73 Billion JPY | 31.38% |
| 2013 FY | 23.9 Billion JPY | 16.25% |
| 2013 Q1 | 4.17 Billion JPY | -37.27% |
| 2013 Q2 | 6.1 Billion JPY | 46.45% |
| 2012 Q2 | 4.9 Billion JPY | 19.62% |
| 2012 Q4 | 6.64 Billion JPY | 35.59% |
| 2012 Q1 | 4.1 Billion JPY | -33.11% |
| 2012 FY | 20.56 Billion JPY | 5.04% |
| 2012 Q3 | 4.9 Billion JPY | -0.12% |
| 2011 Q3 | 4.8 Billion JPY | -0.37% |
| 2011 Q1 | 3.82 Billion JPY | -32.95% |
| 2011 Q4 | 6.13 Billion JPY | 27.79% |
| 2011 FY | 19.57 Billion JPY | 4.49% |
| 2011 Q2 | 4.81 Billion JPY | 26.05% |
| 2010 Q2 | 4.67 Billion JPY | 23.83% |
| 2010 FY | 18.73 Billion JPY | -3.04% |
| 2010 Q4 | 5.7 Billion JPY | 24.17% |
| 2010 Q3 | 4.59 Billion JPY | -1.69% |
| 2010 Q1 | 3.77 Billion JPY | -34.54% |
| 2009 Q2 | 4.83 Billion JPY | 25.6% |
| 2009 Q4 | 5.76 Billion JPY | 18.27% |
| 2009 Q3 | 4.87 Billion JPY | 0.7% |
| 2009 FY | 19.32 Billion JPY | 2.18% |
| 2009 Q1 | 3.85 Billion JPY | -29.89% |
| 2008 Q3 | 4.49 Billion JPY | -9.09% |
| 2008 Q2 | 4.94 Billion JPY | 0.0% |
| 2008 FY | 18.91 Billion JPY | -6.73% |
| 2008 Q4 | 5.49 Billion JPY | 22.31% |
| 2007 FY | 20.27 Billion JPY | -3.36% |
| 2006 FY | 20.98 Billion JPY | 26.9% |
| 2005 FY | 16.53 Billion JPY | 20.82% |
| 2004 FY | 13.68 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | -812.036% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -38425.229% |
| GNI Group Ltd. | 26.01 Billion JPY | -67.259% |
| Linical Co., Ltd. | 12.3 Billion JPY | -253.473% |
| Trans Genic Inc. | 13.08 Billion JPY | -232.519% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -6476.292% |
| Soiken Holdings Inc. | 5.15 Billion JPY | -743.372% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | -2688.089% |
| AnGes, Inc. | 152.98 Million JPY | -28337.429% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -7030.588% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | -240.788% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | -5226.919% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -32005.116% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | -2575.767% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -10056.082% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | -2188.289% |
| Chiome Bioscience Inc. | 682.46 Million JPY | -6274.695% |
| Kidswell Bio Corporation | 2.43 Billion JPY | -1689.42% |
| PeptiDream Inc. | 28.71 Billion JPY | -51.521% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -68913.928% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -35854.545% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -60423511.111% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -108970.625% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | -864.518% |
| FunPep Company Limited | 530 Thousand JPY | -8208390.566% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -62723.105% |
| Stella Pharma Corporation | 269.49 Million JPY | -16043.396% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -13631.859% |
| Cuorips Inc. | 23.1 Million JPY | -188217.029% |
| K Pharma,Inc. | 1 Billion JPY | -4250.5% |
| ReproCELL Incorporated | 2.42 Billion JPY | -1692.677% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | -2436.26% |
| StemCell Institute Inc. | 2.48 Billion JPY | -1653.39% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | -1630.378% |
| CellSeed Inc. | 190.13 Million JPY | -22781.231% |